Philippe Fagnoni

407 total citations
36 papers, 295 citations indexed

About

Philippe Fagnoni is a scholar working on Oncology, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Philippe Fagnoni has authored 36 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Epidemiology and 7 papers in Economics and Econometrics. Recurrent topics in Philippe Fagnoni's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Philippe Fagnoni is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Philippe Fagnoni collaborates with scholars based in France, Italy and United States. Philippe Fagnoni's co-authors include Boris Guiu, Patrick Hillon, Samuel Limat, Serge Aho, Mathieu Boulin, Virginie Nerich, Jean–Pierre Cercueil, Laurent Bedenne, Séverine Guiu and Bruno Chauffert and has published in prestigious journals such as European Journal of Cancer, BMC Cancer and Cancer Immunology Immunotherapy.

In The Last Decade

Philippe Fagnoni

34 papers receiving 290 citations

Peers

Countries citing papers authored by Philippe Fagnoni

Since Specialization

Citations

This map shows the geographic impact of Philippe Fagnoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Fagnoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Fagnoni more than expected).

Fields of papers citing papers by Philippe Fagnoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Fagnoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Fagnoni. The network helps show where Philippe Fagnoni may publish in the future.

Co-authorship network of co-authors of Philippe Fagnoni

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Fagnoni. A scholar is included among the top collaborators of Philippe Fagnoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Fagnoni. Philippe Fagnoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review of Economic Evaluations 2022 ·Clinical Genitourinary Cancer ·(unknown), (unknown), Antoine Thiery-Vuillemin, (unknown), Philippe Fagnoni, Virginie Nerich	4
2	Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management? 2020 ·Journal of Thrombosis and Thrombolysis ·(unknown), Éric Benzenine, Philippe Fagnoni, Catherine Quantin	4
3	Economic evaluations of cancer immunotherapy: a systematic review and quality evaluation 2020 ·Cancer Immunology Immunotherapy ·(unknown), Philippe Fagnoni, F. Aubin, Virginie Westeel, Tristan Maurina, Antoine Thiery-Vuillemin, (unknown), Marie Kroemer, Christophe Borg, Samuel Limat, Virginie Nerich	11
4	A systematic review of economic evaluation in pancreatic ductal adenocarcinoma 2017 ·European Journal of Cancer ·(unknown), Philippe Fagnoni, Angélique Vienot, Christophe Borg, Samuel Limat, (unknown), (unknown), (unknown), Marine Jary, Virginie Nerich	12
5	Telemedicine: Economic and clinical evaluation of the management of ischemic stroke 2017 ·(unknown), (unknown), (unknown), Marie Hervieu‐Bègue, Benoît Delpont, Yannick Béjot, Catherine Lejeune, Philippe Fagnoni	3
6	Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial 2016 ·Trials ·Astrid Pozet, Catherine Lejeune, (unknown), Tienhan Sandrine Dabakuyo‐Yonli, (unknown), Philippe Fagnoni, (unknown), (unknown), Virginie Nerich, (unknown), (unknown), Muriel Bonin, Amélie Anota, Franck Bonnetain	12
7	La sécurisation par l’informatisation des prescriptions : les médicaments administrés sont-ils ceux prescrits ? 2015 ·Le Pharmacien Hospitalier et Clinicien ·(unknown), (unknown), (unknown), (unknown), (unknown), Philippe Fagnoni, (unknown)	1
8	Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma 2014 ·Digestive and Liver Disease ·Mathieu Boulin, (unknown), Boris Guiu, Serge Aho, Jean–Pierre Cercueil, (unknown), Philippe Fagnoni, Anne Minello, (unknown), Patrick Hillon, Laurent Bedenne, Côme Lepage	16
9	Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemia 2014 ·Annales Pharmaceutiques Françaises ·Annelie A Monnier, (unknown), Philippe Fagnoni, Serge Aho, (unknown), C Sgro, (unknown), Delphine Croisier, P. Chavanet, Marie‐Lorraine Chrétien, Denis Caillot, Mathieu Boulin	0
10	Impact économique des stratégies de recours à l’éphédrine en seringues préremplies 2013 ·Annales Françaises d Anesthésie et de Réanimation ·(unknown), (unknown), (unknown), Philippe Fagnoni	10
11	Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patients 2012 ·Diagnostic and Interventional Imaging ·(unknown), Mathieu Boulin, (unknown), Boris Guiu, Serge Aho, (unknown), C Pernot, (unknown), Patrick Hillon, Philippe Fagnoni	9
12	Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma 2011 ·Anti-Cancer Drugs ·Mathieu Boulin, Séverine Guiu, Bruno Chauffert, Serge Aho, Jean–Pierre Cercueil, François Ghiringhelli, D. Krausé, Philippe Fagnoni, Patrick Hillon, Laurent Bedenne, Boris Guiu	64
13	Impact économique de la chimioembolisation avec microsphères chargées dans le traitement du carcinome hépatocellulaire 2011 ·Bulletin du Cancer ·(unknown), Mathieu Boulin, Boris Guiu, C Pernot, Jean–Pierre Cercueil, Serge Aho, (unknown), Laurent Bedenne, Patrick Hillon, (unknown), Philippe Fagnoni	10
14	Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma 2009 ·HAL (Le Centre pour la Communication Scientifique Directe) ·Philippe Fagnoni, Nöel Milpied, Samuel Limat, Éric Deconinck, Virginie Nerich, (unknown), Philippe Colombat, Jean Roy, Marie-Christine Woronoff-Lemsi	1
15	Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkinʼs Lymphoma 2009 ·PharmacoEconomics ·Philippe Fagnoni, Nöel Milpied, Samuel Limat, Éric Deconinck, Virginie Nerich, Charles Foussard, Philippe Colombat, Jean‐Luc Harousseau, Marie-Christine Woronoff-Lemsi	10
16	Mise en place de recommandations pour la prise en charge des infections fongiques au CHU de Besançon 2008 ·Journal de Mycologie Médicale ·J. Leroy, Frédéric Grenouillet, J C Navellou, Philippe Fagnoni, (unknown), Éric Deconinck, Guillermo Blasco, (unknown), (unknown), Bruno Hoen	1
17	Hospital Costs of Renal Transplant Management 2008 ·Transplantation Proceedings ·(unknown), Philippe Fagnoni, Virginie Nerich, Samuel Limat, (unknown), J.M. Chalopin, Hugues Bittard, M.‐C. Woronoff‐Lemsi	5
18	Does hospitalisation affect hypnotic and anxiolytic drug prescribing? 2007 ·Pharmacy World & Science ·Philippe Fagnoni, Samuel Limat, Émmanuel Haffen, (unknown), Micheline Jacquet, D. Sechter, (unknown)	14
19	Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer 2006 ·Supportive Care in Cancer ·Philippe Fagnoni, Samuel Limat, L. Chaigneau, Emmanuel Guardiola, (unknown), Bernard Schmitt, Yacine Merrouche, Xavier Pivot, Marie-Christine Woronoff-Lemsi	9
20	Malaise hypotensif d'origine iatrogène chez une patiente inobservante 2002 ·Journal de Pharmacie Clinique ·Philippe Fagnoni, (unknown), H. Gil, (unknown), (unknown), J.L. Dupond, M.‐C. Woronoff‐Lemsi	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact